Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human ...
At two Senate confirmation hearings, Kennedy played down his well-publicised questioning of the safety of childhood vaccines ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...
The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...
A meeting of vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, raising new ...
The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...
GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...
The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback